Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Medtronic recalls data management software, urging healthcare providers to run update
The error caused incorrect glucose data to be displayed to clinicians. According to Medtronic, any treatment decisions or recommendations based on those data need to be revisited.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
Abbott shares safety concerns with millions of CGM sensors—7 deaths reported
Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.
Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs
The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.
Adjustable interatrial shunt for heart failure shows promise in first-in-human trial
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Very low doses of edoxaban are safe and effective for frail, elderly AFib patients

Elderly patients are often not eligible for oral anticoagulant therapy due to the risk of bleeding events or other adverse outcomes. A very low dose of edoxaban, however, appears to be a safe treatment option, even for especially frail patients.

coronavirus COVID-19 vaccine vaccination

Moderna sues Pfizer, BioNTech over COVID-19 vaccine patent

"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," says Moderna CEO Stéphane Bancel.

The Abbott Cephea transcatheter mitral valve replacement (TMVR) system.

Cardiologist praises updated design of new TMVR system after historic interventional procedure

A care team with the Sanger Heart & Vascular Institute has shared details about its recent successes in TMVR and TAVR. Cardiologist Michael Rinaldi, MD, highlighted the importance of having "a coordinated team of specialists with expertise in treating valve diseases."

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

Polypill strategy improves odds of survival after a heart attack

The new findings, presented during ESC Congress 2022 and published in the New England Journal of Medicine, suggest that prescribing these new-look pills to heart patients could boost outcomes while also improving medication adherence.

Pediatric radiologists skillfully read emergency breast ultrasound—but patients may shrug off discharge instructions

For this reason, these patients may need pointed guidance upon ED discharge lest cancers go undetected in early stages.

What to expect at the TCT MedTech Innovation Forum during TCT 2022

The all-day summit, a collaboration between CRF and Fogarty Innovation, will focus on advances in healthcare technologies and patient care.

FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system

This latest recall was initiated because electrical faults could cause the batteries to stop working, which leads to a risk of serious injury or death.

USPSTF highlights the benefits of statin use among high-risk CVD patients in new recommendations

The USPSTF recommends statin use for high-risk patients between the ages of 40 to 75 to help prevent a first heart attack or stroke. Other patients in that same age group may also benefit, the group noted, but physician input is needed.

Clinical

Medtronic recalls data management software, urging healthcare providers to run update

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

Abbott shares safety concerns with millions of CGM sensors—7 deaths reported

Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial